How ACE Inhibitors Lower Blood Pressure: Mechanism Explained
ACE inhibitors (angiotensin-converting enzyme inhibitors) are a cornerstone of hypertension treatment. They lower blood pressure through a cascade of effects on the renin-angiotensin-aldosterone system (RAAS):
- Inhibit ACE: Block conversion of angiotensin I to angiotensin II, a potent vasoconstrictor.
- Vasodilation: Reduced angiotensin II → blood vessels relax and widen → decreased peripheral resistance → lower BP.
- Reduce aldosterone: Less angiotensin II → less aldosterone secretion → increased sodium and water excretion → reduced blood volume → lower BP.
- Increase nitric oxide and bradykinin: Enhance vasodilation and improve endothelial function (contributes to BP lowering but also causes the characteristic dry cough in some patients).
Clinical Uses
- Hypertension
- Heart failure with reduced ejection fraction
- Post-myocardial infarction
- Diabetic nephropathy (renoprotection)
- Chronic kidney disease
Monitoring
Regular checks of blood pressure, kidney function (creatinine, eGFR), and potassium are essential due to risks of hyperkalemia and acute kidney injury, especially in volume-depleted patients or those on other RAAS blockers.
Hypertension - Related Articles
- Normal Blood Pressure for Men Over 65: Guidelines and Targets
- Obesity & Blood Pressure: Understanding the Connection
- Antihypertensive Medications: Benefits, Side Effects, and Collaborative Management Strategies
- Plendil (Felodipine) Side Effects: What to Expect
- Can an Argument Predict Your Blood Pressure? Understanding Acute Stress Response
- Understanding Blood Pressure: Systolic vs. Diastolic, Categories, and Management
- Understanding Hypertension: Potential Complications & Management
